|
Neurogen Corporation Stage: Growth Date of Investment: 2004 Web Site : http://www.neurogen.com Stock Symbol : NASDAQ: NRGN |
 |
Neurogen Corp. is a small molecule drug discovery company with over 15
years of experience in discovering drugs against challenging targets
using its proprietary drug discovery technology. In 2004, Warburg
Pincus invested $60 million in Neurogen to lead a $100 million common
stock private placement. Founded in 1987 and public since 1990,
Neurogen initially focused on disorders of the central nervous system,
but over the last few years has diversified into a range of diseases,
imcluding insomnia, pain, obesity, and depression. The Company’s
powerful technology platform has generated a robust product pipeline to
address these inportant disease states. Neurogen is based in Branford,
Conn.
